We are live on ! Find out more
NBP

NovaBridge Biosciences American Depositary Shares

120 hedge funds and large institutions have $657M invested in NovaBridge Biosciences American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 58 increasing their positions, 22 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 22

0.14% more ownership

Funds ownership: 21.79%21.93% (+0.14%)

9% less funds holding

Funds holding: 132120 (-12)

36% less call options, than puts

Call options by funds: $3.45M | Put options by funds: $5.36M

39% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 28

40% less funds holding in top 10

Funds holding in top 10: 106 (-4)

64% less capital invested

Capital invested by funds: $1.83B → $657M (-$1.17B)

Holders
120
Holders Change
-12
Holders Change %
-9.09%
% of All Funds
1.89%
Holding in Top 10
6
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-40%
% of All Funds
0.09%
New
17
Increased
58
Reduced
22
Closed
28
Calls
$3.45M
Puts
$5.36M
Net Calls
-$1.91M
Net Calls Change
-$2.33M
Name Holding Trade Value Shares
Change
Change in
Stake
Ensign Peak Advisors
101
Ensign Peak Advisors
Utah
$44K
Nomura Asset Management
102
Nomura Asset Management
Japan
$37.4K
SAM
103
Shell Asset Management
Netherlands
$34K -$267K -10,400 -83%
SP
104
Sage Partners
Hong Kong
$33K -$5.07M -197,946 -99%
Royal Bank of Canada
105
Royal Bank of Canada
Ontario, Canada
$29K +$2.02K +79 +5%
Simplex Trading
106
Simplex Trading
Illinois
$27K +$41K +1,600 +1,553%
PNC Financial Services Group
107
PNC Financial Services Group
Pennsylvania
$14K +$10.9K +424 +100%
Wells Fargo
108
Wells Fargo
California
$11K +$17.7K +691 New
AIG
109
American International Group
New York
$7K
CG
110
Cutler Group
California
$6K +$10.3K +400 New
GWS
111
Glassman Wealth Services
Virginia
$5K +$5K +195 +156%
CI Investments Inc
112
CI Investments Inc
Ontario, Canada
$5K +$7.28K +284 New
Daiwa Securities Group
113
Daiwa Securities Group
Japan
$2K
CIBC Private Wealth Group
114
CIBC Private Wealth Group
Georgia
$2K +$2.56K +100 New
Rockefeller Capital Management
115
Rockefeller Capital Management
New York
$1K
QCG
116
Quadrant Capital Group
Ohio
$1K +$794 +31 +155%
LOIM
117
Liberty One Investment Management
Illinois
$1K +$1.77K +69 New
ED
118
Exane Derivatives
France
$227
Macquarie Group
119
Macquarie Group
Australia
$37
National Bank of Canada
120
National Bank of Canada
Quebec, Canada
-$13.7M -289,300 Closed
BG
121
Bellevue Group
Switzerland
-$6.87M -144,957 Closed
QC
122
Quaero Capital
Switzerland
-$3.61M -76,159 Closed
SVI
123
Strategic Vision Investment
Hong Kong
-$2.93M -61,800 Closed
DCM
124
Discovery Capital Management
Connecticut
-$2.19M -46,200 Closed
PAMI
125
Perseverance Asset Management International
Cayman Islands
-$1.74M -36,678 Closed

NBP Hedge Fund Activity: Q1 2022 in Review

120 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q1 2022, worth a combined $657M — down 64% from $1.83B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of NBP and 17 opened new positions — a net loss of 11 holders — while 22 trimmed existing stakes and 58 added.

The largest buyer was Artisan Partners, adding an estimated $26M. The largest seller was T. Rowe Price Associates, cutting an estimated $50.1M.

  • 120 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q1 2022, down from 132 in Q4 2021.
  • Funds reported $657M of NovaBridge Biosciences American Depositary Shares stock for Q1 2022, down 64% quarter-over-quarter.
  • 17 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q1 2022 and 28 closed out, a net change of -11 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q1 2022 was Artisan Partners, an estimated $26M added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q1 2022 was T. Rowe Price Associates, an estimated $50.1M sold.

Based on aggregated 13F filings for Q1 2022.